In the first instalment of a two-part roundtable discussion on the fallout from CREST-2, William Gray (Main Line Health, Philadelphia, USA) is joined in the CX Studio by Sonya Noor (Buffalo Endovascular and Vascular Surgical Associates, Buffalo, USA) and Richard Bulbulia (University of Oxford, Oxford, UK) to talk through the implications for medical therapy, carotid stenting and endarterectomy in the context of asymptomatic carotid artery stenosis.
Watch the second instalment—Unpacking CREST-2, part two: “It’s a public health benefit to revascularize patients based on CREST-2”—here.
